⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10500212 | 1.00 | — | — | |
| SCHEMBL1903917 | 1.00 | — | — | |
| Fumaric Acid SCHEMBL342742 | 0.84 | — | — | |
| Maleic Acid SCHEMBL532168 | 0.84 | — | — | |
| Fumaric Acid SCHEMBL342743 | 0.84 | — | — | |
| Fumaric Acid SCHEMBL2138822 | 0.84 | TSHR (0.90) | — | |
| Fumaric Acid SCHEMBL2139580 | 0.84 | TSHR (0.90) | — | |
| SCHEMBL244945 | 0.84 | — | — | |
| SCHEMBL244944 | 0.84 | — | — | |
| SCHEMBL258961 | 0.84 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 81 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3080610-A1 | UNIVERSAL ANTIGEN RETRIEVAL COMPOUNDS AND METHODS OF USE | University of Houston System (US) | 2016-10-19 | — | — | EP | claimed |
| WO-2015088667-A1 | UNIVERSAL ANTIGEN RETRIEVAL COMPOUNDS AND METHODS OF USE | UNIVERSITY OF HOUSTON SYSTEM (US) | 2015-06-18 | — | — | WO | claimed |
| US-20150168417-A1 | Universal Antigen Retrieval Compounds and Methods of Use | UNIVERSITY OF HOUSTON SYSTEM (US) | 2015-06-18 | — | — | US | claimed |
| CN-101914171-B | Sulfonic acid ultraviolet (UV)-cured aqueous epoxy emulsion and preparation method thereof | UNIV SOUTH CHINA TECH | 2012-02-08 | — | — | CN | claimed |
| CN-101914171-A | Sulfonic acid ultraviolet (UV)-cured aqueous epoxy emulsion and preparation method thereof | UNIV SOUTH CHINA TECH | 2010-12-15 | — | — | CN | claimed |
| EP-3315968-B1 | UNIVERSAL ANTIGEN RETRIEVAL COMPOUNDS AND METHODS OF USE | UNIV HOUSTON SYSTEM (US) | 2025-10-15 | — | — | EP | disclosed |
| US-12037354-B2 | Cyclic pantetheine derivatives and uses thereof | VECTIVBIO COMET AG (CH) | 2024-07-16 | — | — | US | disclosed |
| US-12017997-B2 | Host-targeted pan-respiratory antiviral small molecule therapeutics | PROSETTA BIOSCIENCES, INC. (US) | 2024-06-25 | — | — | US | disclosed |
| US-20240190826-A1 | Novel Host-Targeted Pan-Respiratory Antiviral Small Molecule Therapeutics | PROSETTA BIOSCIENCES, INC. | 2024-06-13 | — | — | US | disclosed |
| CN-117586256-A | Substituted heterocyclic compounds | 首药控股(北京)股份有限公司 | 2024-02-23 | — | — | CN | disclosed |
| EP-4313067-A1 | TREATMENT OF IMMUNE-RELATED DISORDERS, KIDNEY DISORDERS, LIVER DISORDERS, HEMOLYTIC DISORDERS, AND OXIDATIVE STRESS-ASSOCIATED DISORDERS USING NRH, NARH AND REDUCED DERIVATIVES THEREOF | Mitopower LLC (US) | 2024-02-07 | — | — | EP | disclosed |
| WO-2024006445-A1 | METHODS FOR TREATMENT OF CANCER | FRONTIER MEDICINES CORPORATION (US) | 2024-01-04 | — | — | WO | disclosed |
| EP-1939205-A1 | TRICYCLIC COMPOUND | Daiichi Sankyo Company, Limited (JP) | 2008-07-02 | — | — | EP | disclosed |
| WO-2007071085-A1 | IMPROVEMENTS IN OR RELATED TO ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2007-06-28 | — | — | WO | disclosed |
| US-20070129348-A1 | Receptor antagonist | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2007-06-07 | — | — | US | disclosed |
| US-20060199795-A1 | Receptor agonists | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2006-09-07 | — | — | US | disclosed |
| EP-1623710-A1 | RECEPTOR ANTAGONIST | Takeda Pharmaceutical Company Limited (JP) | 2006-02-08 | — | — | EP | disclosed |
| EP-1591120-A1 | RECEPTOR AGONISTS | Takeda Chemical Industries, Ltd. (JP) | 2005-11-02 | — | — | EP | disclosed |
| WO-1992000972-A1 | RENIN INHIBITING COMPOUNDS | ABBOTT LABORATORIES (US) | 1992-01-23 | — | — | WO | disclosed |
| US-4551277-A | 4-(3-Acylamino-2-oxo-1-azetidinyl)-4-oxo-2-butenoic acid | E. R. SQUIBB & SONS, INC. (US) | 1985-11-05 | — | — | US | disclosed |